U.S. Healthtech Stock News

Talos Energy FY 2025 earnings recap Talos Energy (TALO) closed out FY 2025 with fourth quarter revenue of US$392.2 million and a basic EPS loss of US$1.19, alongside a full year trailing twelve month revenue base of about US$1.8 billion and a loss of US$2.82 per share. Over recent quarters, the company has seen quarterly revenue move from US$509.1 million in Q3 2024 to US$512.9 million in Q1 2025 and then within a US$392.2 million to US$450.0 million range through Q4 2025. Basic EPS shifted...

CleanSpark (CLSK) moved into focus after its latest quarterly report, where a wider-than-expected net loss coincided with management spotlighting a shift toward high-performance computing and AI infrastructure tied to new data center leases. See our latest analysis for CleanSpark. The share price reaction around the recent earnings and AI data center update comes against a mixed backdrop. There has been a 12.73% 7-day share price return, but a 16.00% 30-day and 22.30% 90-day share price...

Tri Pointe Homes (TPH) just posted its FY 2025 numbers with fourth quarter revenue of US$972.6 million and basic EPS of US$0.71, alongside full year trailing twelve month revenue of US$3.5 billion and EPS of US$2.73. Over the past six quarters, revenue has moved from US$1.25 billion in Q4 2024 to US$972.6 million in Q4 2025, while quarterly EPS shifted from US$1.39 to US$0.71. Investors now have to weigh these results against a trailing net margin that sits at 6.9% compared with 10.2% a year...

Himax Technologies (HIMX) has put fresh numbers on the table, reporting fourth quarter 2025 revenue of US$203.08 million and net income of US$6.34 million, alongside softer full year results and cautious first quarter 2026 guidance. See our latest analysis for Himax Technologies. The latest results and cautious first quarter 2026 outlook come after a mixed share price pattern, with a 7 day share price return of 3.0% and a 90 day share price return of 4.12% contrasted by a 1 year total...

Adient (ADNT) has drawn fresh attention after introducing Sculpted Soft Trim, a new seat trim product aimed at improving vehicle interior design, cutting sewing labor, and simplifying complex shapes for automaker customers. See our latest analysis for Adient. The Sculpted Soft Trim launch comes as Adient’s share price sits at US$24.79, with a 30 day share price return of 16.06% and a year to date share price return of 30.20%. This points to building momentum despite a 3 year total shareholder...

Ares Management (NYSE:ARES) has appointed Michael Harper as head of portfolio management for systematic credit. The move comes as private credit faces increased scrutiny around liquidity risks after Blue Owl Capital imposed withdrawal restrictions. Investors are watching how large alternative asset managers respond to liquidity concerns across their private credit offerings. Ares Management, trading at $119.18, sits at the center of the conversation on private credit given its scale and...

InfuSystem Holdings (INFU) has wrapped up FY 2025 with Q4 revenue of US$36.2 million and basic EPS of US$0.10, capping a year in which trailing twelve month revenue reached US$143.4 million and EPS came in at US$0.32. The company has seen quarterly revenue move from US$33.8 million in Q4 2024 to US$36.5 million in Q3 2025 and US$36.2 million in Q4 2025, while basic EPS shifted from US$0.04 in Q4 2024 through a low of US$0.01 loss in Q1 2025 before landing between US$0.10 and US$0.12 over the...

Clear Secure FY 2025 earnings snapshot Clear Secure (YOU) has wrapped up FY 2025 with fourth quarter revenue of US$240.8 million and basic EPS of US$0.31, alongside trailing 12 month revenue of US$900.8 million and EPS of US$1.14 that frame the latest print in a broader earnings context. Over recent periods the company has seen quarterly revenue move from US$198.4 million in Q3 2024 to US$240.8 million in Q4 2025, while basic EPS has shifted from US$0.25 to US$0.31 across the same span...

In February 2026, Amphastar Pharmaceuticals received U.S. FDA approval for its Ipratropium Bromide HFA Inhalation Aerosol as a generic equivalent to Boehringer Ingelheim's Atrovent HFA, including 180 days of marketing exclusivity for COPD maintenance treatment. This short period of exclusivity offers Amphastar a time-limited window to build presence in the inhaled COPD market while supporting its broader mix of generic and proprietary products. Next, we’ll examine how the 180-day exclusivity...

AbbVie (NYSE:ABBV) is committing $380 million to build two advanced manufacturing facilities in the U.S. for neuroscience and obesity medicines. The new sites are expected to support next generation production using artificial intelligence and create about 300 jobs. AbbVie also received FDA approval for the first all oral, fixed duration combination regimen for chronic lymphocytic leukemia. For a company already known for its immunology and oncology portfolio, these two moves mark a...

Life Time Group Holdings (LTH) closed out FY 2025 with Q4 revenue of US$745.1 million, basic EPS of US$0.56 and net income excluding extra items of US$123 million, set against a year in which trailing twelve month revenue reached US$3.0 billion, EPS was US$1.71 and net income was US$373.7 million. Over the past few quarters, the company has seen revenue move from US$663.3 million and EPS of US$0.18 in Q4 2024 to US$745.1 million and EPS of US$0.56 in Q4 2025. Trailing EPS stepped up from...

UFP Technologies (UFPT) has wrapped up FY 2025 with Q4 revenue of US$148.9 million and basic EPS of US$2.28, framed by trailing twelve month revenue of US$602.8 million and EPS of US$8.87 that reflect earnings growth of 15.8% over the past year. The company has seen revenue move from US$504.4 million and EPS of US$7.69 on a trailing basis in Q4 2024 to US$602.8 million and EPS of US$8.87 by Q4 2025, which sets the scene for investors to weigh solid earnings expansion against a slightly softer...

Angel Oak Mortgage REIT (AOMR) has just posted its FY 2025 results, with Q4 total revenue of US$16.7 million and basic EPS of US$0.46, while trailing 12 month revenue came in at US$61.0 million and basic EPS at US$1.86, alongside reported earnings growth of 54% over the year. Over recent quarters the company has seen total revenue range from US$23.5 million and basic EPS of US$0.88 in Q1 2025, to US$5.9 million and basic EPS of US$0.03 in Q2, US$14.9 million and basic EPS of US$0.49 in Q3,...

Range Resources (RRC) has wrapped up FY 2025 with fourth quarter revenue of US$913.9 million and basic EPS of US$0.75, alongside net income excluding extra items of US$178.0 million, capping a year where trailing twelve month revenue reached US$3.1 billion and EPS came in at US$2.77. Over the past year the company has seen revenue move from US$2.4 billion to US$3.1 billion on a trailing basis, while net income excluding extra items has gone from US$265.0 million to US$658.0 million and basic...

Recent Results Set Against a Shifting Earnings Outlook Oddity Tech (NasdaqGM:ODD) has wrapped up FY 2025 with fourth quarter revenue of US$152.7 million and basic EPS of US$0.10, alongside trailing twelve month revenue of US$809.8 million and EPS of US$1.95 that sit against a 9.1% year over year earnings increase and a net margin of 13.7%. Over the past year, the company has seen quarterly revenue move from US$123.6 million in Q4 2024 to US$268.1 million in Q1 2025, US$241.1 million in Q2,...

Bloomin' Brands FY 2025 earnings snapshot Bloomin' Brands (BLMN) has wrapped up FY 2025 with Q4 revenue of US$975.2 million and a basic EPS loss of US$0.14, as net income excluding extra items came in at a loss of US$12.2 million. Over the past few quarters, revenue has ranged from US$928.8 million to US$1.05 billion while EPS has swung from a profit of US$0.50 in Q1 to a loss of US$0.54 in Q3 and a smaller loss in Q4. This combination presents a mixed picture on earnings quality and...

Morningstar (MORN) has been back in focus after reporting quarterly results that exceeded analyst expectations on revenue and EPS, along with new retirement products, a leadership hire in its Direct Platform business, and a completed share repurchase. See our latest analysis for Morningstar. Despite the recent earnings beat, new retirement products, and leadership changes, Morningstar’s share price performance has been weak, with a 30 day share price return of 18.38% and a 1 year total...

Postal Realty Trust (PSTL) has just wrapped up FY 2025 with fourth quarter revenue of US$26.0 million and basic EPS of US$0.25, alongside trailing 12 month revenue of US$95.8 million and basic EPS of US$0.58 that frame the latest numbers in a fuller earnings picture. Over the past few reporting periods, the company has seen revenue move from US$21.4 million in Q4 2024 to US$26.0 million in Q4 2025, while quarterly basic EPS shifted from US$0.17 to US$0.25, setting up this result against a...

Astec Industries (ASTE) has wrapped up FY 2025 with fourth quarter revenue of US$400.6 million and basic EPS of US$0.52, alongside trailing twelve month revenue of about US$1.4 billion and basic EPS of US$1.70. This gives a clearer view of full year profitability. Over recent periods the company has seen quarterly revenue move from US$291.4 million in Q3 2024 to US$359 million in Q4 2024, then to US$329.4 million, US$330.3 million, US$350.1 million and US$400.6 million through FY 2025...

Marqeta (MQ) has wrapped up FY 2025 with Q4 total revenue of US$172.1 million and a basic EPS loss of US$0.00 per share, alongside net income excluding extra items of a US$1.4 million loss, putting fresh numbers behind a business that is still loss making but closely watched for its path toward profitability. The company has seen quarterly revenue move from US$127.97 million in Q3 2024 to US$135.79 million in Q4 2024 and then to US$172.11 million in Q4 2025, while basic EPS losses over that...

Darden Restaurants (NYSE:DRI) has been recognized for strong operational performance and quality metrics after passing a respected quality investing screen. The recognition highlights the company’s financial discipline and effective management, drawing fresh attention from long term investors focused on business quality. Darden Restaurants, trading at $212.06, is coming off a stretch of steady share performance that may catch your eye if you track longer time frames. The stock is up 13.3%...

SiriusPoint’s FY 2025 earnings in focus SiriusPoint (SPNT) closed FY 2025 with fourth quarter revenue of US$762.3 million and basic EPS of US$2.05, alongside net income of US$239.9 million. This marked a clear break from the loss reported in the prior year’s fourth quarter, when revenue was US$638.7 million and EPS was US$0.11 with net income of US$17.8 million. Over the last twelve months in this dataset, revenue has moved from US$2.66 billion and EPS of US$1.06 to US$2.98 billion and EPS of...

AbCellera Biologics (ABCL) closed out FY 2025 with Q4 revenue of US$44.9 million and a basic EPS loss of US$0.03, alongside trailing 12 month revenue of US$75.1 million and a full year basic EPS loss of US$0.49, providing a snapshot of a business still investing heavily ahead of profitability. Over the past few quarters, the company reported revenue of US$4.2 million in Q1 2025, US$17.1 million in Q2, US$9.0 million in Q3 and US$44.9 million in Q4, while quarterly EPS losses moved from...

Western Union (NYSE:WU) is moving to acquire International Money Express, Inc. (Intermex), with the deal expected to close in Q2 2026. The company is planning a new digital asset network and a U.S.-dollar stablecoin as part of its push into digital services. Western Union is also pursuing exclusive partnerships with major retail outlets to extend its reach in cross border and digital payments. Western Union, trading at around $9.7 per share, is reshaping its business with a mix of...